Sunday, October 17, 2004 10:45:10 PM
Preferred in the case of Biofrontera seems to be used to identify the investor base (A Investors and B Investors) as opposed to the original founders shares (Common Shares).
BUT, the agreement also makes clear that DNAPrint is entitled to receive it's Pro-Rata share of any profits generated by Biofrontera retroactive to January 1, 2004. Why the retroactive date I haven't a clue, but that's the agreement.
Later,
W2P
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM